1. Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer

3. Overview

4. Goals of This Program

5. Case 1

6. Recommendations for First-Line Treatment of NSCLC

7. Factors to Consider When Choosing Between Doublet and Triplet Regimens

8. irAEs

9. Case 1 (cont)

10. Recommendations for Patients With NSCLC Who Have Disease Progression

11. Examples of Potential AEs With Docetaxel-Ramucirumab

12. Case 1 (cont)

13. Considerations in Patients With Diarrhea

14. Case 2

15. Treatment Considerations

16. Case 2 (cont)

17. Treatment Considerations

18. NCCN Treatment Recommendations

19. Management of irAEs

20. Clinical Pearls

21. Clinical Pearls (cont)

22. Abbreviations